Sort
10,766 grants matching “checkpoint inhibitor”
Image-guided, sonoporation-enhanced immunotherapy for pancreatic cancer treatment
$17,439Samantha Marie Fix · Univ Of North Carolina Chapel Hill · F31 · FY2018 · CA
Targeting RIG-I activation to signal tumor cell killing and anti-tumor immunity in breast cancer
$17,309David Elion · Vanderbilt University · F31 · FY2019 · CA
Biospecimen Acquisition, Processing and Classification Unit
$17,254George Victor Thomas · Oregon Health & Science University · U2C · FY2022 · CA
Overcoming resistance to cancer immunotherapy by targeting MDSC-derived adenosine
$16,892Kavitha Yaddanapudi · University Of Louisville · P20 · FY2023 · GM
A Novel Pathway Involving ATM, PP1 and I-2
$16,881Bo Xu · Methodist Hospital Research Institute · R01 · FY2010 · ES
NLR and Oral Cancer Immune Escape
$16,440Blake Heath · University Of Michigan At Ann Arbor · F31 · FY2021 · DE
Gene and Virus Therapy Program
$16,215Evanthia Galanis · Mayo Clinic Rochester · P30 · FY2019 · CA
Defining the Mechanism and Function of DNA Double Strand Break Induced Inhibition of V(D)J Recombination
$15,906Rebecca Ann Glynn · University Of Pennsylvania · F31 · FY2023 · AI
Combination therapies involving novel cancer vaccines
$15,827Ravi Madan · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Mechanisms of Action in UmuD in Regulating DNA Damage-Induced Genes in a umuC-Deficient Bacterium
$15,614Janelle M Hare · Morehead State University · R15 · FY2023 · GM
Full Project 1: Understanding and Targeting of Convergent Immunosuppressive Pathways and Molecular Signaling in HPV-Positive and HPV-Negative Penile Cancer
$15,178Magaly Martinez-Ferrer · University Of Puerto Rico Med Sciences · U54 · FY2020 · CA
Cancer Cell Biology and Signaling Research Program
$15,119Vivek M Rangnekar · University Of Kentucky · P30 · FY2018 · CA
Innate Immune Memory: From Evolutionary Roots to Human Disease
$15,000Thale Cross Jarvis · Keystone Symposia · R13 · FY2022 · AI
Signaling and Biotechology Program
$14,689Hui-Kuan Lin · Wake Forest University Health Sciences · P30 · FY2019 · CA
Mechanism of LSD1 Function and Its Therapeutic Application for Progressive Oral Malignancy
$14,491Manish Bais · Boston University Medical Campus · R01 · FY2024 · DE
ALDH Inhibition as Modulator of Tumor Immunobiology
$14,478Ronald J Buckanovich · Magee-Women'S Res Inst And Foundation · R01 · FY2022 · CA
Defining immune footprint in tumor microenvironment following high salt synergized inflammatory cytokine mediated breast cancer progression
$13,904Jens Marc Titze · Vanderbilt University Medical Center · U54 · FY2020 · CA
PD-1 Blockade and Neoantigen-Specific T Cell Immunity
$13,740Gerald P Linette · University Of Pennsylvania · R21 · FY2017 · CA
MECHANISMS OF DNA DAMAGE TRIGGERED S PHASE CHECKPOINTS
$13,697State University Of New York At Buffalo · R01 · FY2005 · CA
Cancer Cell Biology and Signaling Research Program
$13,346Vivek M Rangnekar · University Of Kentucky · P30 · FY2018 · CA
CV301 and Anti-PD-1 Therapy in Non-Small Cell Lung Cancer
$13,264Arun Rajan · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
SPINDLE CHECKPOINT SIGNALING
$12,768Kevin S Hardwick · University Of Washington · P41 · FY2011 · RR
Development of First-in-Class RIPK1 Degraders to Improve Cancer Immunotherapies
$12,570Jin Wang · Baylor College Of Medicine · R01 · FY2025 · CA
Cancer Cell Biology and Signaling Research Program
$12,500Vivek M Rangnekar · University Of Kentucky · P30 · FY2018 · CA
HDAC6-Selective Inhibitors for Pancreatic Cancer Treatment
$12,356Werner Tueckmantel · Psychogenics, Inc. · R43 · FY2009 · CA